1. Home
  2. LAKE vs SPRO Comparison

LAKE vs SPRO Comparison

Compare LAKE & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Industries Inc.

LAKE

Lakeland Industries Inc.

HOLD

Current Price

$8.64

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.32

Market Cap

136.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAKE
SPRO
Founded
1982
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.3M
136.7M
IPO Year
1986
2017

Fundamental Metrics

Financial Performance
Metric
LAKE
SPRO
Price
$8.64
$2.32
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$17.33
$5.00
AVG Volume (30 Days)
459.7K
280.4K
Earning Date
12-09-2025
11-13-2025
Dividend Yield
1.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,456,000.00
$40,549,000.00
Revenue This Year
$19.87
N/A
Revenue Next Year
$8.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
27.42
N/A
52 Week Low
$7.77
$0.51
52 Week High
$27.28
$3.22

Technical Indicators

Market Signals
Indicator
LAKE
SPRO
Relative Strength Index (RSI) 27.58 47.60
Support Level $7.77 $2.26
Resistance Level $8.90 $2.42
Average True Range (ATR) 0.60 0.08
MACD -0.10 0.00
Stochastic Oscillator 11.64 27.15

Price Performance

Historical Comparison
LAKE
SPRO

About LAKE Lakeland Industries Inc.

Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: